The FDA approved rituximab in combination with chemotherapy for several pediatric cancer indications.

New insight into the top reasons for COVID-19 vaccine hesitancy among underrepresented populations with rheumatic diseases was the top story in rheumatology last week.

Most studies on traumatic brain injury, particularly when it comes to military populations and blast injuries, have enrolled men, either primarily or exclusively.

The addition of darolutamide to docetaxel and androgen deprivation therapy significantly prolonged OS among men with metastatic hormone-sensitive prostate cancer, according to topline results of the randomized phase 3 ARASENS trial.

The FDA has announced a final amendment to classify intraoperative orthopedic strain sensors into class II with special controls, which will allow for increased patient access to innovative implant strain devices, according to a release.

Emese Zsiros, MD, PhD, has been promoted to lead the department of gynecologic oncology at Roswell Park Comprehensive Cancer Center.

An initiative launched in dozens of Michigan hospitals more than doubled the rate of appropriate antibiotic prescribing for patients hospitalized with community-acquired pneumonia, researchers reported.

Modification of the Rome criteria into the new clinical practice model may reduce unnecessary diagnostics and enhances the patient-provider relationship, according to research published in Gastroenterology.

Ticagrelor added to low-dose aspirin reduced the risk for spontaneous MI, MI related to stent thrombosis and STEMI compared with placebo in patients with diabetes and CAD, according to a new analysis of the THEMIS trial.

The FDA granted priority review to luspatercept-aamt for treatment of anemia among adults with non-transfusion-dependent beta-thalassemia.